Author Description

The volumes in this series are published annually on the occasion of the International Conference on Dialysis organized by the Renal Research Institute, New York, in collaboration with the ISN, ISPD, NKF and RPA. Among the topics discussed in the current issue are the relationship between the metabolic syndrome, diabetes and kidney disease; implications of the MPO trial with regard to the value of high-flux dialysis; conservative dialytic therapy versus active treatment in elderly patients; the relation of uremic toxins and the clinical state of uremia; the influence of body composition on the outcome of kidney disease and hypertension; new strategies in extracorporeal blood purification in sepsis and sepsis-related acute renal failure; the effect of ESA on hemoglobin concentration and outcomes; and renal implications of the management of decompensated heart failure. Identifying relevant controversial issues as well as areas where progress has recently been made with regard to disease processes or treatment, this publication is a most helpful reference tool for both clinicians and basic investigators involved in hemodialysis.